InChI=1S/C16H26O5/c1-2-3-4-5-11(17)6-7-12-13(8-9-16(20)21)15(19)10-14(12)18/h6-7,12-15,18-19H,2-5,8-10H2,1H3,(H,20,21)/b7-6+/t12-,13-,14-,15+/m1/s1 |
BZVKQDSLFYXLAI-BNBDNKSYSA-N |
CCCCCC(=O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCC(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
View more via ChEBI Ontology
Outgoing
|
2,3,4,5-tetranor-15-oxoprostaglandin F2α
(CHEBI:73983)
has role
metabolite
(CHEBI:25212)
2,3,4,5-tetranor-15-oxoprostaglandin F2α
(CHEBI:73983)
is a
enone
(CHEBI:51689)
2,3,4,5-tetranor-15-oxoprostaglandin F2α
(CHEBI:73983)
is a
oxo monocarboxylic acid
(CHEBI:35871)
2,3,4,5-tetranor-15-oxoprostaglandin F2α
(CHEBI:73983)
is a
prostanoid
(CHEBI:26347)
2,3,4,5-tetranor-15-oxoprostaglandin F2α
(CHEBI:73983)
is a
secondary alcohol
(CHEBI:35681)
|
|
(13E)-9α,11α-dihydroxy-2,3,4,5-tetranor-15-oxoprosta-13-en-1-oic acid
|
3-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E)-3-oxooct-1-en-1-yl]cyclopentyl}propanoic acid
|
15-keto-2,3,4,5-tetranor-PGF2α
|
ChEBI
|
15-keto-2,3,4,5-tetranorprostaglandin F2α
|
ChEBI
|
2,3,4,5-tetranor-15-keto-PGF2α
|
ChEBI
|
2,3,4,5-tetranor-15-oxo-PGF2α
|
ChEBI
|
2,3,4,5-tetranor-15-oxo-prostaglandin F2α
|
ChEBI
|
|